Questions and answers about pain medicine dangers

(AP) -- A Food and Drug Administration panel has recommended limits on Tylenol and other drugs containing acetaminophen because of risks for liver failure. Maximum recommended doses for over-the-counter Tylenol would be reduced. Percocet and Vicodin, two narcotic prescription drugs containing acetaminophen, would be banned.

Q: What's the reason?

A: It's easy to get too much acetaminophen because the drug is in many medicines and a few extra doses a day can cause liver problems.

Q: I've taken at recommended doses for years. Could I be damaging my liver and should I get tested?

A: Doctors say recommended doses are safe and they aren't recommending routine tests; possible liver damage can be detected with blood tests.

Q: Would I know if I have liver damage?

A: Liver damage from excess acetaminophen tends to cause sudden symptoms, within a few days of taking too much. These may include nausea, vomiting and jaundice - yellowing of the skin or whites of the eyes.

Q: What should I do if I've taken extra doses and develop these symptoms?

A: Seek immediate medical care. Quick treatment with medicine can prevent permanent ; waiting too long can be fatal.

Q: How can I avoid getting too much acetaminophen?

A: Carefully read drug labels; don't exceed recommended doses and don't take more than one medicine containing . Also, avoid drinking alcohol while using acetaminophen-containing drugs.

Q: Are the proposed limits likely to be adopted?

A: The full FDA has not taken any action but will likely consider the recommendations separately. Its decisions are months away.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Explore further

FDA group recommends acetaminophen liver warnings

Citation: Questions and answers about pain medicine dangers (2009, July 7) retrieved 4 June 2020 from https://medicalxpress.com/news/2009-07-pain-medicine-dangers.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments